0001556244-19-000112.txt : 20191206
0001556244-19-000112.hdr.sgml : 20191206
20191206184329
ACCESSION NUMBER: 0001556244-19-000112
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191205
FILED AS OF DATE: 20191206
DATE AS OF CHANGE: 20191206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carroll Khristine L
CENTRAL INDEX KEY: 0001672352
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11737
FILM NUMBER: 191274032
MAIL ADDRESS:
STREET 1: 229 ANDOVER STREET
CITY: WILMINGTON
STATE: MA
ZIP: 01887
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AdvanSource Biomaterials Corp
CENTRAL INDEX KEY: 0001011060
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043186647
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 229 ANDOVER STREET
CITY: WILMINGTON
STATE: MA
ZIP: 01887
BUSINESS PHONE: 978-657-0075
MAIL ADDRESS:
STREET 1: 229 ANDOVER STREET
CITY: WILMINGTON
STATE: MA
ZIP: 01887
FORMER COMPANY:
FORMER CONFORMED NAME: CARDIOTECH INTERNATIONAL INC
DATE OF NAME CHANGE: 19960321
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-12-05
0
0001011060
AdvanSource Biomaterials Corp
ASNB
0001672352
Carroll Khristine L
229 ANDOVER STREET
WILMINGTON
MA
01887
0
1
0
0
SVP
Common Stock
2019-12-05
4
X
0
100000
0.06
A
385309
D
Common Stock
2019-12-05
4
X
0
350000
0
A
735309
D
Common Stock
2019-12-05
4
X
0
600000
0
A
1335309
D
Shares acquired through the exercise of options granted pursuant to the 2003 Stock Option Plan at an exercise price of $0.06 per share in consideration of cash.
Shares acquired from the exercise of options pursuant to the 2017 Non-Qualified Equity Incentive Plan (the "2017 Plan") which provided for the exercise of options into 500,000 shares of the Company's common stock at an exercise price of $0.06 per share which were exercised on a cashless basis, as provided for in the 2017 Plan, resulting in the issuance of 350,000 shares, net.
Shares acquired from the exercise of options granted pursuant to the 2017 Non-Qualified Equity Incentive Plan (the "2017 Plan") which provided for the exercise of options into 750,000 shares of the Company's common stock at an exercise price of $0.04 per share which were exercised on a cashless basis, as provided for in the 2017 Plan, resulting in the issuance of 600,000 shares, net.
/s/ Khristine Carroll
2019-12-06